Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives
Advanced Functional Materials · 2023-09 · 33 (37)
DOI: 10.1002/adfm.202302673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 24.05.2023. Verfasst von Saqer Al Abdullah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanoengineering, Joint School of Nanoscience and Nanoengineering, North Carolina A&T State University, 2907 East Gate City Boulevard, G…. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is one of the main causes of dementia worldwide, whereby neuronal death or malfunction leads to cognitive impairment in the elderly population. AD is highly prevalent, with increased projections over the next few decades. Yet current diagnostic methods for AD occur only after the presentation of clinical symptoms. Evidence in the literature points to potential mechanisms of AD induction beginning before clinical symptoms start to present, such as the formation of amyloid beta (A β ) extracellular plaques and neurofibrillary tangles (NFTs). Biomarkers of AD, including A β 40 , A β 42 , and tau protein, amongst others, show promise for early AD diagnosis. Additional progress is made in the application of biosensing modalities to measure and detect significant changes in these AD biomarkers within patient samples, such as cerebral spinal fluid (CSF) and blood, serum, or plasma. Herein, a comprehensive review of the emerging nano‐biomaterial approaches to develop biosensors for AD biomarkers’ detection is provided. Advances, challenges, and potential of electrochemical, optical, and colorimetric biosensors, focusing on nanoparticle‐based (metallic, magnetic, quantum dots) and nanostructure‐based biomaterials are discussed. Finally, the criteria for incorporating these emerging nano‐biomaterials in clinical settings are presented and assessed, as they hold great potential for enhancing early‐onset AD diagnostics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nanoengineering, Joint School of Nanoscience and Nanoengineering, North Carolina A&T State University, 2907 East Gate City Boulevard, Greensboro, NC 27401, USA.
- School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada.
- Department of Mechanical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L7, Canada.
- Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4K1, Canada.
- Institute for Infectious Disease Research (IIDR), 1280 Main St W, McMaster University, Hamilton, ON L8S 4L8, Canada.
Förderung
- NCATS NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Al Abdullah, S., Najm, L., Ladouceur, L., Ebrahimi, F., Shakeri, A., Al-Jabouri, N., Didar, T. F., & Dellinger, K. (2023). Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives. Advanced Functional Materials, 33(37). https://doi.org/10.1002/adfm.202302673
Vancouver
Al Abdullah S, Najm L, Ladouceur L, Ebrahimi F, Shakeri A, Al-Jabouri N, et al. Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives. Advanced Functional Materials. 2023;33(37). doi:10.1002/adfm.202302673
BibTeX
@article{AlAbdullah2023,
author = {Al Abdullah, Saqer and Najm, Lubna and Ladouceur, Liane and Ebrahimi, Farbod and Shakeri, Amid and Al-Jabouri, Nadine and Didar, Tohid F and Dellinger, Kristen},
title = {Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives},
journal = {Advanced Functional Materials},
year = {2023},
volume = {33},
number = {37},
doi = {10.1002/adfm.202302673}
}
EUVIMED